Difference between revisions of "Example orders for CapeOx (XELOX) in colon cancer"
Jump to navigation
Jump to search
(Created page with "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC...") |
m |
||
| Line 23: | Line 23: | ||
Monitoring: | Monitoring: | ||
| − | * | + | *Hold if ANC <1000 or platelets <100 and notify physician. |
'''Comments:''' | '''Comments:''' | ||
*My institution uses the schedule described by [[Colon_cancer#CapeOx_.28XELOX.29|Haller, et al. 2011]]. | *My institution uses the schedule described by [[Colon_cancer#CapeOx_.28XELOX.29|Haller, et al. 2011]]. | ||
Revision as of 04:56, 3 July 2012
Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.
CapeOx (XELOX)
CapeOX: Capecitabine, OXaliplatin
XELOX: XELoda, OXaliplatin
Original reference may be found at CapeOx (XELOX)
Example regimen #1
- Capecitabine (Xeloda) 1000 mg/m2 PO BID on days 1-14
- Oxaliplatin (Eloxatin) 130 mg/m2 IV over 2 hours on day 1
- Mix in 500 mL D5W, and only infuse through D5W line.
21-day cycles x 8 cycles
Supportive medications:
- Ondansetron (Zofran) 8 mg IV 30 minutes prior to chemotherapy
- Dexamethasone (Decadron) 10 mg IV 30 minutes prior to chemotherapy
- Calcium gluconate 1 g & magnesium sulfate 1 g (admixed together) IV, given over 30 minutes, to start prior to oxaliplatin to decrease likelihood of neuropathy
- Calcium gluconate 1 g & magnesium sulfate 1 g (admixed together) IV, given over 30 minutes, to start after oxaliplatin infusion is complete to decrease likelihood of neuropathyHydration:
- 500 ml D5W at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml D5W.
Monitoring:
- Hold if ANC <1000 or platelets <100 and notify physician.
Comments:
- My institution uses the schedule described by Haller, et al. 2011.